|  | Conditions & Treatments | Skin Conditions

Tretinoin (Schederma) for Acne: Mechanism, Usage, and Safety

Schederma is a brand name for tretinoin (all-trans retinoic acid), a topical retinoid. It is FDA-approved for acne vulgaris (and photoaging). The original statement that it is not FDA-approved is incorrect.

Mechanism of Action

  • Binds nuclear retinoic acid receptors (RARα, β, γ) → modulates gene transcription.
  • Normalizes follicular keratinization: Prevents microcomedone formation (precursor to all acne lesions).
  • Reduces inflammation: Inhibits TLR2, AP-1, NF-κB pathways.
  • Enhances penetration of other topicals (benzoyl peroxide, antibiotics).
  • Long-term: Increases collagen, reduces photoaging.

Formulations & Strengths

  • Cream 0.025%, 0.05%, 0.1% (less irritating).
  • Gel 0.01%, 0.025%, 0.05% (more penetrating, drying).
  • Microsphere gel (Retin-A Micro) — slower release, less irritation.
  • Lotion (Altreno) — hydrating base.

Usage Protocol

  1. Start low: 0.025% cream or 0.01% gel, 2–3×/week at night.
  2. Pea-sized amount for full face; avoid eyes, lips, nasal mucosa.
  3. Moisturize first (wait 20 min) or "sandwich" (moisturizer → tretinoin → moisturizer).
  4. Titrate frequency → nightly as tolerated (4–12 weeks).
  5. Sunscreen mandatory: SPF 30+ daily — photosensitivity.

Expected Timeline

  • Weeks 1–4: "Retinoid purge" — flare, dryness, scaling, erythema.
  • Weeks 4–12: Improvement begins.
  • Months 3–6: Maximal benefit; maintenance.

Contraindications & Precautions

  • Pregnancy: Category C (topical); avoid — teratogenic risk (oral retinoids Category X).
  • Breastfeeding: Minimal absorption; generally compatible but discuss.
  • Eczema, rosacea, sunburn — barrier compromised → delay.
  • Concurrent benzoyl peroxide: Use separate times (BP oxidizes tretinoin).

Tretinoin is the gold-standard topical for acne and photoaging. Patience and barrier support are key to tolerability.

Skin Conditions - Related Articles